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Abstract
Background: With the increased manufacture and use of carbon nanoparticles (CNP) there has
been increasing concern about the potential toxicity of fugitive CNP in the workplace and ambient
environment. To address this matter a number of investigators have conducted in vitro and in vivo
toxicity assessments. However, a variety of different approaches for suspension of these particles
(culture media, Tween 80, dimethyl sulfoxide, phosphate-buffered saline, fetal calf serum, and
others), and different sources of materials have generated potentially conflicting outcomes. The
quality of the dispersion of nanoparticles is very dependent on the medium used to suspend them,
and this then will most likely affect the biological outcomes.
Results:  In this work, the distributions of different CNP (sources and types) have been
characterized in various media. Furthermore, the outcome of instilling the different agglomerates,
or size distributions, was examined in mouse lungs after one and seven days. Our results
demonstrated that CNP suspended in serum produced particle suspensions with the fewest large
agglomerates, and the most uniform distribution in mouse lungs. In addition, no apparent clearance
of instilled CNP took place from lungs even after seven days.
Conclusion: This work demonstrates that CNP agglomerates are present in all dispersing vehicles
to some degree. The vehicle that contains some protein, lipid or protein/lipid component disperses
the CNP best, producing fewer large CNP agglomerates. In contrast, vehicles absent of lipid and
protein produce the largest CNP agglomerates. The source of the CNP is also a factor in the
degree of particle agglomeration within the same vehicle.
Background
In the last decade there has been a dramatic increase in
research and technology at the nanometer scale. Carbon
nanoparticles (CNP) are an important component of this
nanotechnology revolution due to the unique electrical,
physical and thermal qualities of these particles [1]. CNP
exist in three primary forms – fullerene carbon spheres
(C60CS), single-walled nanotubes (SWNT) and multi-
walled nanotubes (MWNT). Another variant of the
MWNT is the double-walled nanotube, which will not be
addressed in this study. These particles are generated
through a variety of methods including electrical arc dis-
charge, laser vaporization, chemical-vapor deposition
(CVD), and high pressure carbon monoxide (HiPco) [2].
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All of these production methods produce some metal con-
taminants, typically Fe, Ni, Y, and Co [2].
Previous studies have reported CNP toxicity in mouse and
rat models [3-5], but there is little known about the mech-
anism of CNP toxicity. The unique physical characteristics
of these particles present a new class of material because
of their size and extreme hydrophobic nature. This study
focuses specifically on the characterization of CNP in
regards to particle source and methods of dispersion for
biomedical studies. Dispersion studies have been done on
SWNT using various surfactants and polymers [6], but the
results were not translatable to biological research because
the vehicles described would be toxic to most biological
systems.
In vitro and in vivo toxicology studies have used a variety
of strategies regarding CNP dispersion into a biological
vehicle. CNP vehicles have included cell culture media [7-
9], with and without fetal calf serum (FCS), pluronic sur-
factant [10], mouse serum [3], fetal calf serum (FCS) [11],
1% Tween 80 in phosphate buffered saline (PBS) [4,12],
PBS alone [5], dimethyl sufoxide (DMSO) [13], Tyrode's
solution [14], and tetrahydrofuran (THF) solvent to create
water-soluble fullerenes [15]. Another variable with
regard to these studies is the variety of sources for similar
particle types of CNP produced by different methods con-
taining different contaminants. The end result has been a
difference in findings regarding the cytotoxicty and mech-
anism of action of various CNP in biological models.
The purpose of this study is to give researchers a frame of
reference with regard to CNP agglomeration in a variety of
media. The hypothesis of this work is that all dispersing
media (at least the one's used to date) produce some
degree of CNP agglomeration. In addition, optimal dis-
persion of CNP in a biological system must include some
lipid and/or protein component. The relative dispersion
characteristics of any given CNP must be determined
empirically because CNP from different sources have var-
iable dispersion characteristics in the same media.
Results
Relative dispersal of CNP in various media vehicles
In order to compare agglomeration properties of CNP,
various suspension media vehicles were selected based on
the types used in previous publications. CNP were sus-
pended at 5 mg/ml and 10 µl samples were analyzed by
light microscopy at 400× magnification to examine rela-
tive CNP agglomeration states. Figures 1 thru 7 are organ-
ized whereby each figure represents a suspension media.
The progression from Figure 1 to Figure 7 represents the
best CNP dispersal media to the worst CNP dispersal
media. CNP types from different sources are placed side-
by-side for reference (e.g., A compared to B, C compared
to D, and E compared to F). Figures A, C and E are CNP
from SES Research and B, D and F are CNP from alterna-
tive sources (described below).
Descriptive data (median size area and maximum size
area) on all dispersed CNP can be found in Table 1. These
data were obtained by ImagePro software as described in
Methods. Vehicles that produced mass agglomeration
(e.g., SWNT and MWNT in 1% tween 80 and DMSO),
were omitted from the table and analyses. All images that
could be analyzed for particle area produced similar expo-
nential histograms with a large number of smaller
agglomerates and a small number of large agglomerates
(with some being very large relative to the median
agglomerate area). A larger median area indicates the pres-
ence of more frequent large agglomerates, whereas the
maximum area is the area for the largest single agglomer-
ate analyzed indicating the most extreme agglomerate
state for a particular CNP in a particular media. Taken
together, the results in Table 1 indicate that the median
areas for all suspended agglomerates are relatively consist-
ent regardless of particle type or vehicle. In contrast, the
area of the largest observed agglomerate is extremely vari-
Carbon nanoparticles suspended in 100% fetal calf serum  (FCS) Figure 1
Carbon nanoparticles suspended in 100% fetal calf 
serum (FCS). A) C60CS from SES Research, B) C60CS 
from BuckyUSA, C) SWNT from SES Research, D) SWNT 
from CNI, E) MWNT from SES Research, and F) MWNT 
from NanoLab. All particle suspensions were at 5 mg/ml. 
Magnification – 400×.Particle and Fibre Toxicology 2007, 4:6 http://www.particleandfibretoxicology.com/content/4/1/6
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able depending on particle type, particle source and vehi-
cle used.
CNP suspended in 100% FCS are shown in Figure 1.
C60CS dispersed well with only a few visible large
agglomerates (Figures 1A and 1B). SWNT (Figures 1C and
1D) dispersed with uniform small CNP agglomerates. The
only visible difference between the SWNT agglomeration
states is that the SWNT from SES agglomerated in clumps,
whereas the SWNT from CNI agglomerated in fibre-like
stands. The MWNT appeared to agglomerate in uniform
small to medium sized clumps regardless of source (Fig-
ures 1E and 1F).
CNP suspended in 7.5% BSA/PBS are shown in Figure 2.
There was a significant difference in how the C60CS dis-
persed in this media with the SES C60CS forming large
and small agglomerates (Figure 2A), with the C60CS from
BuckyUSA forming only few visible small agglomerates
(Figure 2B). The SWNT appeared to disperse in a similar
manner to what was described in Figures 1C and 1D, with
the formation of uniform small agglomerates (Figure 2C
and 2D). The MWNT appeared to disperse better in this
media compared to FCS with the formation of small visi-
ble agglomerates (Figures 2E and 2F). However, larger
agglomerates appeared in the MWNT from NanoLab (Fig-
ure 2F).
CNP suspended in RPMI media with 10% FCS are shown
in Figure 3. With regard to C60CS, this vehicle was very
similar to the BSA/PBS with large agglomerates only
appearing in the SES C60CS sample (Figure 3A), although
larger agglomerates were also present in the BuckyUSA
C60CS sample (Figure 3B). This is possibly the best dis-
persal media for SWNT and MWNT from SES as only
small agglomerates were visible (Figure 3C and 3E). In
contrast, SWNT from CNI became a swirling mass
agglomerate (Figure 3D), and MWNT from NanoLab
formed very large agglomerates (Figure 3F). This figure
illustrates how CNP from different sources can be com-
pletely different with regard for formation of agglomer-
ates in a particular vehicle.
Carbon nanoparticles suspended in RPMI media with 10%  fetal calf serum (FCS) Figure 3
Carbon nanoparticles suspended in RPMI media with 
10% fetal calf serum (FCS). A) C60CS from SES 
Research, B) C60CS from BuckyUSA, C) SWNT from SES 
Research, D) SWNT from CNI, E) MWNT from SES 
Research, and F) MWNT from NanoLab. All particle suspen-
sions were at 5 mg/ml. Magnification – 400×.
Carbon nanoparticles suspended in 7.5% bovine serum albu- min (BSA) in phosphate buffered saline (PBS) Figure 2
Carbon nanoparticles suspended in 7.5% bovine 
serum albumin (BSA) in phosphate buffered saline 
(PBS). A) C60CS from SES Research, B) C60CS from Buck-
yUSA, C) SWNT from SES Research, D) SWNT from CNI, 
E) MWNT from SES Research, and F) MWNT from 
NanoLab. All particle suspensions were at 5 mg/ml. Magnifi-
cation – 400×.Particle and Fibre Toxicology 2007, 4:6 http://www.particleandfibretoxicology.com/content/4/1/6
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CNP suspended in 100% delipidated FCS are shown in
Figure 4. This vehicle appears to be a good dispersing
media for all CNP with the exception of C60CS from SES
where very large agglomerates formed (Figure 4A), and
MWNT from NanoLab with the formation of some larger
agglomerates (Figure 4F). The other CNP only created
small agglomerates in this vehicle.
Figure 5 illustrates the CNP suspended in 1% tween 80 in
PBS. This represents the first of the generally poor disper-
sal vehicles. Large agglomerates appeared with C60 from
SES (Figure 5A). In contrast, this vehicle dispersed well for
C60CS from BuckyUSA (Figure 5B). The SWNT from SES
formed a cloud of agglomerated CNP with some more
solid agglomerates visible (Figure 5C). The SWNT from
CNI formed a swirling massive agglomeration of CNP
(Figure 5D). MWNT from SES dispersed relatively well in
the tween 80 vehicle (Figure 5E), whereas the MWNT
from NanoLab agglomerated similarly to the SWNT sam-
ples described above (Figure 5F).
The results shown in Figure 6 represent another poor dis-
persal vehicle, PBS alone. The PBS vehicle was ineffective
in dispersing both SWNT and MWNT regardless of source,
as massive CNP clumps were apparent (Figure 6C–F). In
contrast, the C60CS from both sources appeared to be rel-
atively dispersed (Figures 6A and 6B).
The worst dispersal vehicle (100% DMSO) is shown in
Figure 7. All CNP tested formed large agglomerates in this
vehicle. The C60CS were characterized by large solid
clumps (Figure 7A and 7B), and the other CNP formed
large loose clusters of agglomerated nanoparticles.
Control particle in the various dispersal media
Figure 8 represents the control particle, which is a crude
fullerene carbon ash dispersed in all 7 of the vehicles
tested. All of the vehicles produced a similar pattern of
dispersal with very small to medium sized agglomerates
formed. The number of agglomerates was larger in these
samples due to the density of the particle compared to
CNP. This figure illustrates that the differences seen in the
CNP suspended in various media above were due to struc-
tural/physical properties in the specific CNP particular to
the nano scale. Crude carbon particles not on the nano
scale do not react to the differences in the vehicle makeup.
Carbon nanoparticles suspended in 1% tween 80 in phos- phate buffer saline (PBS) Figure 5
Carbon nanoparticles suspended in 1% tween 80 in 
phosphate buffer saline (PBS). A) C60CS from SES 
Research, B) C60CS from BuckyUSA, C) SWNT from SES 
Research, D) SWNT from CNI, E) MWNT from SES 
Research, and F) MWNT from NanoLab. All particle suspen-
sions were at 5 mg/ml. Magnification – 400×.
Carbon nanoparticles suspended in 100% delipidated fetal  calf serum (delipFCS) Figure 4
Carbon nanoparticles suspended in 100% delipidated 
fetal calf serum (delipFCS). A) C60CS from SES 
Research, B) C60CS from BuckyUSA, C) SWNT from SES 
Research, D) SWNT from CNI, E) MWNT from SES 
Research, and F) MWNT from NanoLab. All particle suspen-
sions were at 5 mg/ml. Magnification – 400×.Particle and Fibre Toxicology 2007, 4:6 http://www.particleandfibretoxicology.com/content/4/1/6
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Effect of using different dispersal vehicles in SWNT lung 
instillations in a mouse model
In order to determine the effect of the CNP vehicle on
lung dispersion during particle instillation, BALB/c mice
were given 250 µg instillations in either 100% FCS or PBS
(representing the two extreme agglomerate states of the
SWNT). After 24 hours the lungs showed significant dif-
ferences in SWNT deposition as shown in Figure 9. Figure
9A (PBS) and Figure 9B (100% FCS) represent the respec-
tive vehicle controls at 100× magnification. The compara-
tive SWNT dispersion patterns can be found in Figure 9C
and Figure 9D, respectively. The blackened areas represent
the accumulation of SWNT which is more generally dis-
persed in Figure 9D which used the 100% FCS vehicle.
This observation was more pronounced at higher magni-
fications (200×), as illustrated in Figures 9E and 9F. Lung
histology prepared 7 days post-CNP instillation showed
only trace amounts of SWNT in the lungs using the PBS
vehicle (Figure 9G). In contrast, the SWNT instilled with
100% FCS had persisted in the lung tissue and produced
areas of increased cellularity indicative of sustained
inflammation (Figure 9H).
Discussion
Oberdorster et.al., suggested that CNP toxicity could be
dependent on particle size, size distribution, agglomera-
tion state, shape, surface chemistry, surface area, and sur-
face charge [1]. All of these qualities can be affected
directly, or indirectly, by the suspension media makeup.
Researchers should be aware of how CNP toxicity could
be potentially modified by the choice of vehicle or source
of material in a study. Due to the lack of standardization
in CNP research, results may seem contradictory when
compared. For example, using the same CNP types and
similar suspension media Jia et.al., found in vitro toxicity
[8], whereas Hamilton et.al., found very little CNP cyto-
toxicity in vitro [11]. The only variable that could account
for the difference was the different sources of the CNP.
Therefore, contaminants could account for the toxicity
reported for some CNP.
Alternative media for CNP dispersion, mouse bronchoal-
veolar lavage fluid (BALF) and lung surfactant component
dipalmitoyl phosphatidylcholine (DPPC), not included
in this study can be found in Sager et.al.,[16]. Their find-
ings were consistent with ours in that lipid-protein mix-
Carbon nanoparticles suspended in phosphate buffered saline  (PBS) Figure 6
Carbon nanoparticles suspended in phosphate buff-
ered saline (PBS). A) C60CS from SES Research, B) 
C60CS from BuckyUSA, C) SWNT from SES Research, D) 
SWNT from CNI, E) MWNT from SES Research, and F) 
MWNT from NanoLab. All particle suspensions were at 5 
mg/ml. Magnification – 400×.
Carbon nanoparticles suspended in 100% dimethyl sulfoxide  (DMSO) Figure 7
Carbon nanoparticles suspended in 100% dimethyl 
sulfoxide (DMSO). A) C60CS from SES Research, B) 
C60CS from BuckyUSA, C) SWNT from SES Research, D) 
SWNT from CNI, E) MWNT from SES Research, and F) 
MWNT from NanoLab. All particle suspensions were at 5 
mg/ml. Magnification – 400×.Particle and Fibre Toxicology 2007, 4:6 http://www.particleandfibretoxicology.com/content/4/1/6
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ture (BALF or PBS containing protein and DPPC) was the
best dispersant. Use of BALF as a dispersing media for
CNP, although effective, creates problems with reproduc-
ibility (unknown dilution factor) from experiment to
experiment. On the other hand, synthetic lung surfactant
may be a viable alternative, especially for in vivo experi-
ments. Commercial sources of synthetic lung surfactant
can be cost prohibitive, however simple components of
surfactant can be obtained and used for CNP dispersion.
Caution should be exercised in the use of lung surfactant
or its components as a dispersant vehicle due to evidence
that these vehicles can modify the toxicity of other respir-
able particles (diesel soot and silicate dusts) in vivo and in
vitro by surface absorption, altering the surface chemistry
of the particle [17]. A similar effect could occur with CNP.
The results from the current study suggest that some pro-
tein component should be considered in the mixture
regardless of the vehicle choice.
With regard to in vivo particle instillations, we have dem-
onstrated that CNP dispersion is critical to effective distri-
bution throughout the lung. Several earlier studies used
PBS and 1% Tween 80 as the CNP vehicle [4,5,12]. Based
on our findings, the CNP was probably extremely agglom-
erated to the point that it was not distributed evenly in the
lungs. In fact, 2 of the 3 studies reported respiratory block-
age and animal deaths resulting from CNP instillation
[3,4,12]. This probably could have been avoided if other
vehicle options were examined. In contrast, in vivo studies
that used serum as the CNP vehicle [3,11], did not report
these problems (note: Lam et.al., did have to adjust the
CNP amount instilled from the original lethal 1 mg bolus
dose) and probably achieved even distribution through-
out the mouse lungs.
Conclusion
Complete or total dispersion of CNP is not practical in a
biological model. Toxicology studies using a biological
system will be evaluating the CNP with some degree of
agglomeration. The relative CNP agglomeration is deter-
mined by two factors – the stock suspension vehicle and
the source of the material. This study has demonstrated
that the same type of CNP from different sources can
behave differently in the same dispersing media. In addi-
tion, SWNT and MWNT are more prone to agglomeration
than C60CS. The most important factor in how well a
CNP disperses is the presence of protein, lipid or protein/
lipid combination in the suspending vehicle. This finding
is consistent with Sager et.al. [16] where lipid-protein was
necessary for ultrafine carbon black and ultrafine titanium
dioxide dispersion. The absence of lipid or protein in the
vehicle results in relatively large CNP agglomerates, with
protein being the more critical of the two.
Table 1: Agglomerate carbon nanoparticle counts, median area, 
and maximum area
Veh: FCS median area (µm2) max area (µm2)
Crude Fullerenes .003 .878
C60CS (SES) .003 .157
C60CS (BUSA) .003 .076
SWNT (SES) .003 .333
SWNT (CNI) .006 5.915
MWNT (SES) .005 2.851
MWNT (NanoLab) .058 1.462
Veh: 7.5% BSA median area  (µm2) max area (µm2)
Crude Fullerenes .004 .478
C60CS (SES) .024 2.813
C60CS (BUSA) .001 .034
SWNT (SES) .003 .378
SWNT (CNI) .005 .181
MWNT (SES) .002 .127
MWNT (NanoLab) .004 2.344
Veh: RPMI + FCS median area (µm2) max area (µm2)
Crude Fullerenes .004 2.45
C60CS (SES) .004 .842
C60CS (BUSA) .003 .208
SWNT (SES) .002 .434
SWNT (CNI) .005 16.689
MWNT (SES) .002 .093
MWNT (NanoLab) .014 3.825
Veh: FCS (delipid) median area (µm2) max area (µm2)
Crude Fullerenes .004 2.739
C60CS (SES) .127 14.031
C60CS (BUSA) .004 .328
SWNT (SES) .003 .133
SWNT (CNI) .006 .704
MWNT (SES) .002 .105
MWNT (NanoLab) .003 .826
Veh: 1% Tween 80 median area (µm2) max area (µm2)
Crude Fullerenes .003 .995
C60CS (SES) .002 2.379
C60CS (BUSA) .003 .068
SWNT (SES) Lg. agglomerates Lg. agglomerates
SWNT (CNI) Lg. agglomerates Lg. agglomerates
MWNT (SES) .002 .869
MWNT (NanoLab) Lg. agglomerates Lg. agglomerates
Veh: PBS median area (µm2) max area (µm2)
Crude Fullerenes .005 1.567
C60CS (SES) .003 .615
C60CS (BUSA) .003 .096Particle and Fibre Toxicology 2007, 4:6 http://www.particleandfibretoxicology.com/content/4/1/6
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The dispersion of agglomerate CNP is crucial to effective
deposition in the lung for in vivo studies. The establish-
ment of standard reference materials for CNP, and a
standard dispersion protocol would be of great benefit to
toxicology studies, because it would allow researchers to
achieve some degree of concordance. In the absence of
standard reference materials, it is important for all CNP
researchers to be aware that the dispersion characteristics
of any given CNP can be optimized by experimenting
with different vehicles, and that no one vehicle is optimal
for all CNP types or sources. This can only be established
by experimental observation.
This study observed CNP agglomeration on the light
microscopic scale. Although it would have been possible
to have further refined the analysis to higher resolution,
the current study using light microscopic analysis was suf-
ficient to demonstrate a wide variety of agglomeration
states using different dispersion media and CNP from dif-
ferent sources. This study was intended to serve as a frame
of reference for researchers interested in using CNP for
biological studies. We are not suggesting that one disper-
sion media is superior to another, simply that they are dif-
ferent. This study does not address how various dispersion
media can alter CNP biological activity. It is up to each
researcher to determine the effect of dispersing media on
a particular CNP in their specific model system.
Methods
Particles
Several CNP were used for these studies. The particles used
and their respective sources are listed as follows: C60CS
from SES Research (Houston, TX), C60CS from BuckyUSA
(Houston, TX), SWNT from SES Research (Houston TX),
SWNT from Carbon Nanotechnologies Inc. (CNI, Hou-
ston, TX), MWNT from SES Research (Houston, TX),
MWNT from Nanolab (Newton, MA), and crude fullerene
(elemental carbon not on the nanoscale) was used as a
control particle (generous donation from Maria
Morandi). Detailed CNP characterization can be found in
Table 2.
Suspension Media
Various suspension media were used in these studies in
order to demonstrate the hydrophobic characteristics of
CNP, and the potential need for a lipid interaction, caus-
ing better particle dispersion. Seven media were used in
total and they were as follows: cell culture media RPMI
(HEPES buffered w/L-glutamine, MediaTech) with 10%
fetal calf serum (FCS), FCS alone (Hyclone), phosphate
buffered saline (PBS, Diamedix), dimethyl sulfoxide
(DMSO, stored under argon in amber vials, Sigma, St.
Crude carbon fullerenes suspended in various media vehicles Figure 8
Crude carbon fullerenes suspended in various media 
vehicles. A) 100% fetal calf serum (FCS), B) 7.5% bovine 
serum albumin (BSA) in phosphate buffered saline (PBS), C) 
RPMI media with 10% fetal calf serum (FCS), D) 100% delipi-
dated fetal calf serum (delipFCS), E) 1% tween 80 in phos-
phate buffer saline (PBS), F) phosphate buffered saline (PBS), 
and G) 100% dimethyl sulfoxide (DMSO). All particle suspen-
sions were at 5 mg/ml. Magnification – 400×.
SWNT (SES) Lg. agglomerates Lg. agglomerates
SWNT (CNI) Lg. agglomerates Lg. agglomerates
MWNT (SES) Lg. agglomerates Lg. agglomerates
MWNT (NanoLab) Lg. agglomerates Lg. agglomerates
Veh: DMSO median area (µm2) max area (µm2)
Crude Fullerenes .003 .849
C60CS (SES) .008 12.333
C60CS (BUSA) .005 3.90
SWNT (SES) Lg. agglomerates Lg. agglomerates
SWNT (CNI) Lg. agglomerates Lg. agglomerates
MWNT (SES) Lg. agglomerates Lg. agglomerates
MWNT (NanoLab) Lg. agglomerates Lg. agglomerates
Table 1: Agglomerate carbon nanoparticle counts, median area, 
and maximum area (Continued)Particle and Fibre Toxicology 2007, 4:6 http://www.particleandfibretoxicology.com/content/4/1/6
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Louis, MO), 1%Tween80 (Sigma, St. Louis, MO) in PBS,
delipidated FCS (Biomeda Corporation), and 7.5%
bovine serum albumin (BSA)/PBS solution (Sigma, St.
Louis, MO). All particle suspensions were freshly prepared
before instillation by suspension in sterile media and dis-
persed by sonication (Sonicator Ultrasonic Processor –
Misonix, Farmingdale, NY) for one minute and vortexed
for 10 sec before sonication and prior to mounting onto
microscope slide.
Imaging
The various stock CNP suspensions were made at a con-
centration of 5 mg/ml and 10 µl was pipetted onto a pre-
cleaned and charged microscope slide, and cover-slipped.
They were photographed at 400× under white light using
Nuance Imaging software. In order to determine particle
size and count for frequency distribution analysis, Image-
Pro software was employed to determine particle fre-
quency and area. The threshold sensitivity of the imaging
was set to include all visible particles. The area for each
particle was calculated in number of pixels. This pixel
count was then converted to square microns. One square
micron was equal to 12544 pixels. Particle area was calcu-
lated as number of pixels per particle divided by 12544
equalling square microns of particle area.
Animals
Balb/c mice (Jackson Laboratories, Bar Harbor, ME) were
used for all of the in vivo studies. All mice were used at 12
weeks of age. Animals were housed in microisolators on a
12:12 h light-dark cycle. The mice were maintained on an
OVA-free diet and given deionized water ad libitum.
Euthanasia was performed by intraperitoneal injection of
a lethal dose of sodium pentobarbital. All animal proce-
dures were approved by the University of Montana Insti-
tutional Animal Care and Use Committee.
Particle Instillation
All CNP exposures were administered intratracheally at a
dose of 250 µg per mouse. Mice were anesthetized using
100 mg/kg Ketamine and 5 mg/kg Xylazine via IP injec-
tion. Mice were checked after a few minutes to verify that
the anesthetic agents were effective. The mouse was then
placed on its back and feet secured with tape. Hair was
shaved from the upper thorax area and ethanol was
Table 2: Carbon nanoparticle characterization
Source Particle MMethod Purity Contaminants Diameter Length
BuckyUSA C60CS C plasma 99.9% N/A 0.7 nm N/A
SES C60CS C plasma 99.9% N/A 10.18 Å N/A
CNI SWNT HiPco 85% C ash, Fe 0.8 – 1.2 nm 0.1–1 µm
SES SWNT CVD 75% C, Ni, Y < 2 nm 1–5 µm
NanoLab MWNT CVD 95% C, Fe, Co, Ni 30 ± 15 nm 1–5 µm
SES MWNT CVD 75% C, Ni, Y 10 – 30 nm 1–2 µm
Representative photomicrographs of SWNT deposition in  mouse lungs after 24 hours (A thru F) and 7 days (G and H) Figure 9
Representative photomicrographs of SWNT deposition in 
mouse lungs after 24 hours (A thru F) and 7 days (G and H). 
A) Lung morphology following PBS vehicle control instilla-
tion, B) Lung morphology following 100% FCS vehicle con-
trol instillation, C) Lung morphology following 250 µg 
SWNT instillation in PBS vehicle D) Lung morphology fol-
lowing 250 µg SWNT instillation in 100% FCS vehicle, E) 
Lung morphology following 250 µg SWNT instillation in PBS 
vehicle (high mag.), F) Lung morphology following 250 µg 
SWNT instillation in 100% FCS vehicle (high mag.), G) Lung 
morphology 7 days following 250 µg SWNT instillation in 
PBS vehicle H) Lung morphology 7 days following 250 µg 
SWNT instillation in 100% FCS vehicle Magnification – 100× 
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applied. An incision, approximately 1 cm in length was
made using a sterile blade in upper thorax area. Salivary
glands were pushed aside to expose the trachea. Particu-
lates were administered by injection into the trachea using
a 23G sterile needle. The incision was closed with Vet-
Bond adhesive. The mice were monitored until they fully
recovered from the procedure and then returned to the
animal care facility. The mice were left for one or seven
days before removal of the lungs for histological analysis.
Histology
Mice were euthanized by intraperitoneal injection of a
lethal dose of sodium pentobarbital. The whole lungs
were removed are fixed in 4% paraformaldehyde over-
night. They were rinsed in a phosphate saline buffer (PBS)
and processed for paraffin embedding. Sections were cut
at 5 µm and mounted onto charged microscope slides.
They were stained with hematoxylin and eosin (basic H&E
stain) and analysed under white light at various magnifi-
cations.
Statistical Analysis
Nonparametric descriptive statistics including median
area, and maximum area were used to describe the particle
distributions. When particle distributions could be deter-
mined the distribution had an exponential curve with the
frequency of smaller particle areas much greater than the
frequency of larger particle areas resulting in the exponen-
tial fall off in frequency over increasing area.
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